Kit ELISA sandwich TNFRSF11B (OPG) (human): quantitative determination of Hu OPG in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu OPG.
Kit ELISA sandwich TNFRSF11B (OPG) (human): quantitative determination of Hu OPG in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu OPG.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
Acts as a decoy receiver for TNFSF11 / RANKL and thus neutralizes its function in the osteoclastogenesis. Prevents osteoclast activation and promotes osteoclast apoptosis in vitro. Bone homeostasis appears to depend on the local ratio of TNFSF11 to TNFRSF11B. May also play a role in preventing blood calcification. Can act as a decoy receiver for TNFSF10 / TRAIL and protect against apoptosis. The TNFSF10/TRAIL bond blocks inhibition of osteoclastogenesis.
Sensitivity
Sensitivity of the dosage: 1 pg/ml.
Measurement range
Dose range: 1.23 to 900 pg/ml.
Duration of dosing
Total dosage duration: 4 hours 45 min.
Reproducibility
Coefficient of intradose variation < 10%, interdose < 12%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17864220 |
| Specifications |
| Accession number | O00300 |
| Dose range | 1.23 to 900 pg/ml |
| Sensitivity of the dosage | 1 pg/ml |
| Calibration range | 1 pg/ml to 900 pg/ml |
| Dose | ELISA solid-phase sandwich |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Protein family | Other proteins |
| Type of sample | Plasma, Serum, Surnatant |
| Specificity | This ELISA kit shows no cross-reactivity with the cytokines tested: Angiogenin human, BDNF, BLC, ENA-78, FGF-4, IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-4, IL-5, IL-7, IL-8, IL-9, IL-11, IL-12 p70, IL-12 p40, IL-13, IL-15, IL-309, IP-10, G-CSF, GM-CSF, IFN gamma, leptin (OB), MCP-1, MCP- |
| Sufficient for | 10 x 96 dosages |
| Target species | Human |
| For use with (application) | ELISA, protein dosage, protein biology, cancerology, immunology, neuroscience, neurobiology, protein detection, protein analyses |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 4982 |
| Gene symbol(s) | OCIF,OPG,PDB5,TR1 |
| Coefficient of inter-dose variation | < 12% |
| Coefficient of intra-dose variation | < 10% |
| Contents of kits | Washing pad, Dosing diluent concentrate, Chromogen, 96-well pre-coated plate, SAV-HRP, Adhesive plate covers, Biotinylated detection antibody, Stop solution, Calibration |
| Marker or dye | HRP |
| Quantity | 10 x 96 tests |
| Regulatory status | RUO |
| Research disciplines | Apoptosis |
| Synonym | OCIF, OPG, TR1 |
| Target | Human |
| Test time | 1 hour 20 minutes |
| Physical characteristics |
| Volume of sample | Plasma, 50 μl; serum, 50 μl; supernatant, 100 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 hours 45 minutes |
Origin and customs
| Manufacturer ref. | EHTNFRSF11BX10 |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3002 12 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.